Licensed producer Zenabis Ltd. - which is merging with Bevo Agro to become Zenabis Global - is pleased to announce that Daniel Burns will join Zenabis Global as an independent director

VANCOUVER, Nov. 27, 2018 /CNW/ - Bevo Agro Inc. (TSXV: BVO) ("Bevo") and Sun Pharm Investments Ltd. ("Sun Pharm") are pleased to announce that Daniel Burns, on completion of the Bevo-Sun Pharm Transaction, will be an independent director of Zenabis Global Inc. ("Zenabis").

Mr. Burns is an experienced lawyer and corporate executive with over 25 years' experience in law, retail banking and capital markets. He has a wide range of experience leading world class organizations, currently serving as lead director of Rubicon Minerals Corporation. Mr. Burns also runs his own law practice and is CEO of NDC Solutions Inc., an air booking software company that delivers airline product directly to corporate travelers or affinity programs.

"The addition of Daniel Burns to the Board of Directors of Zenabis will bring a strong and strategic perspective to Zenabis' leadership team," said Monty Sikka, President and Director and of Sun Pharm, and proposed director of Zenabis. "Daniel's background as a lawyer, accountant and entrepreneur, as well as his experience as a director for companies across a range of industry sectors, will be a significant asset to Zenabis during this time of rapid growth."

"I am pleased to be joining Zenabis at a defining point in the company's evolution," said Mr. Burns. "The combination of talent and experience at Bevo and Sun Pharm provides Zenabis an unprecedented opportunity and positions Zenabis as a market leader."

Previously, Mr. Burns also served as Chair and Director of World Council of Credit Unions (WOCCU), Credit Union Central of Canada, and Central 1 Credit Union; Lead Director and Chair of the Audit and Corporate Governance Committees at Rubicon Minerals Inc; Director of Accend Capital Corporation, Coast Capital Savings, Co-operators Insurance Group and Addenda Capital Inc.; and as an Advisory Board Member of Desjardins. Mr. Burns holds a Global Executive MBA focused in International Business from University of St. Gallen, Switzerland and the Rotman School of Management, University of Toronto, Canada. Mr. Burns completed the International Company Directors Course (Australian Institute of Company Directors) and holds the ICD.D (Institute of Corporate Directors) and A.C.C. (The Directors College) designations.

As previously announced on October 4, 2018, Bevo and Sun Pharm have entered into an arrangement agreement with respect to a reverse take-over of Bevo (the "Bevo-Sun Pharm Transaction"), and announced that the resulting issuer will change its name to Zenabis Global Inc. ("Zenabis"). Through Sun Pharm's subsidiary licensed producer Zenabis Ltd., Zenabis Global Inc. will have nearly 3.5 million square feet of available production space.1 Completion of the Bevo-Sun Pharm Transaction remains subject to receipt of shareholder and all required regulatory approvals.

_____________________________ 1 After completion of planned expansions

Zenabis Key Milestones

On October 4, 2018 Bevo and Sun Pharm announced the Bevo-Sun Pharm Transaction and the intent of Bevo to change its name to Zenabis Global Inc. upon completion

Bevo and Sun Pharm announced the Bevo-Sun Pharm Transaction and the intent of Bevo to change its name to Zenabis Global Inc. upon completion On October 5, 2018 , Zenabis released a presentation introducing the combined business

, Zenabis released a presentation introducing the combined business As of November 27, 2018 , Zenabis has secured purchase orders from government and third party retailers/distributors in New Brunswick , Nova Scotia , British Columbia , and the Yukon Territory

About Bevo Agro

Bevo Agro is North America's leading supplier of propagated agricultural plants, operating approximately 53 acres of state-of-the-art greenhouse facilities on 98 acres of land in Langley, BC and 20 acres of land in Pitt Meadows, BC. The company has entered into a binding agreement to acquire 10.4 acres of greenhouse space on 50 acres of land in Aldergrove, British Columbia (the "Greenhouse Acquisition"). The Company's main products have been the propagation of vegetable plants such as tomatoes, peppers, cucumbers, and other plants such as bedding plants, flowers and grasses. The Company markets its products to established greenhouse growers, nurseries and retail outlets throughout North America. Zenabis intends to convert the Bevo Langley greenhouse (2.1 million square feet) by March 2020. Zenabis will build and/or acquire additional propagation greenhouse space over the coming year in order to maintain all of Bevo's current food/floral propagation capacity while the current Langley facility is being converted.

About Sun Pharm

Sun Pharm has significant experience in agriculture, technology, pharmaceutical sales, consumer packaged goods, international distribution and brand marketing, with cannabis and cannabis-related purchase orders from the provinces of New Brunswick, British Columbia, Nova Scotia, and Yukon Territory. Sun Pharm is currently a privately-held cannabis company which has one of the largest, federally licensed indoor medical cultivation footprints in Canada, operating two licensed production facilities in British Columbia and New Brunswick, with a third expected to be coming online shortly in Nova Scotia. These facilities encompass 660,000 square feet of indoor pharmaceutical grade cannabis production space, strategically positioned on Canada's coasts, facilitating national distribution and access to international markets. Sun Pharm is currently working towards globally recognized EU GMP certifications. Sun Pharm has a management team with decades of experience in the industry, with expertise in retail consumer packaged goods, global pharmaceutical sales and manufacturing, quality assurance, and commercialized cultivation. The growing team has more than two decades of experience in organic cultivation and distribution of herbs and nutraceutical products throughout the Americas, North Africa, and the Middle East. Sun Pharm's sales team has more than two decades in product development, commercialization, and retail and pharmaceutical sales including international distribution.

This news release contains statements that may constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information may include, among others, statements regarding the future plans, costs, objectives or performance of Bevo, or the assumptions underlying any of the foregoing. In this news release, words such as "may", "would", "could", "will", "likely", "believe", "expect", "anticipate", "intend", "plan", "estimate" and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, such future performance will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur, including the completion of the Transaction. Forward-looking information is based on information available at the time and/or management's good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions and other unpredictable factors, many of which are beyond Bevo's control. These risks, uncertainties and assumptions include, but are not limited to, those described Bevo's Management's Discussion & Analysis for the fiscal year ended June 30, 2018, a copy of which is available on SEDAR at www.sedar.com, and could cause actual events or results to differ materially from those projected in any forward-looking statements. Bevo does not intend, nor does Bevo undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events or circumstances or otherwise, except if required by applicable laws.

For more information, visit: https://www.zenabis.com .

SOURCE Bevo Agro Inc.

For further information: [email protected], 1-844-523-8679

Related Links

http://www.bevofarms.com

